Abstract LB-208: Radiation-induced Liver Fibrosis is Mitigated by Gene Therapy Against Transforming Growth Factor-SS Signaling in the Rat

Du Shi-suo,Zeng Zhao-Chong,Qiang Min,Zhang Zheng-Yu,Liu Zhong-shan
DOI: https://doi.org/10.1158/1538-7445.am10-lb-208
IF: 11.2
2010-01-01
Cancer Research
Abstract:Abstract Purpose: We investigated whether blockage the Transforming growth factor (TGF)-ß signaling ameliorated established liver radiation-induced liver fibrosis (RILF). Materials and Methods: A replication-defective adenoviral vector expressing the extracellular portion of mouse TßRII and the Fc portion of human immunoglobulin IgG fusion protein(AdT RIIFc) was produced. The entire liver was exposed to 30 Gy irradiation to generate a RILF model (RILFM). Then, RILFM animals were treated with AdT RIIFc (1× 1011 PFU, TßRII), Control virus (1×1011 PFU, AdGFP), or saline (SALIN). Delayed radiation liver injury was assessed using histology, morphometry, and immunohistochemistry. Chronic oxidative stress damage, hepatic stellate cell (HSC) activation, and hepatocyte regeneration were also analyzed. Results: Blocking TGF-ß signaling with AdT RIIFc successfully mitigated established radiation induced liver fibrosis (RILF). Compared with RILFM or AdGFP rats, AdT RIIFc-treated mice exhibited less oxidative stress damage, less HSC activation, preserved liver function. Conclusions: Modulation of TGF-ß with AdT RIIFc is feasible and ameliorates established radiation-induced liver fibrosis. These data confirm the putative role of TGF-ß in delayed radiation-induced liver damage. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr LB-208.
What problem does this paper attempt to address?